Citation Impact
Citing Papers
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
A randomized trial of paroxetine to prevent interferon-α-induced depression in patients with hepatitis C
2007
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder
2009
Preventing Relapse of Major Depression During Interferon-α Therapy for Hepatitis C—A Pilot Study
2007
The Second Canadian Symposium on Hepatitis C Virus: A Call to Action
2013 StandoutNobel
Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression
2008
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Depressive disorders—is it time to endorse different pathophysiologies?
2005
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
The Rebirth of Neuroscience in Psychosomatic Medicine, Part I: Historical Context, Methods, and Relevant Basic Science
2009
Psychiatric and Substance Use Disorders in Individuals with Hepatitis C
2006
Mechanisms of cytokine-induced behavioral changes: Psychoneuroimmunology at the translational interface
2008
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors
2013
Neuropsychiatric Adverse Effects of Interferon-??
2005
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Assessment of positive emotions in animals to improve their welfare
2007 Standout
The interplay between the intestinal microbiota and the brain
2012 Standout
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
2013
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Effects of Interferon-Alpha on Rhesus Monkeys: A Nonhuman Primate Model of Cytokine-Induced Depression
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Treating viral hepatitis C: efficacy, side effects, and complications
2006
Cytokines, stressors, and clinical depression: Augmented adaptation responses underlie depression pathogenesis
2005
Cytokines as mediators of depression: What can we learn from animal studies?
2005
Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression
2010
Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders
2009
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment
2008
Management of HCV and HIV infections among people who inject drugs
2011
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
2010 Standout
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
The molecular neurobiology of depression
2008 StandoutNature
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development
2017 Standout
The Role of Inflammation in the Pathophysiology of Depression: Different Treatments and Their Effects
2011
Replication of hepatitis C virus
2007 StandoutNobel
Current Approaches to HCV Infection in Current and Former Injection Drug Users
2008
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
2010 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Development of a multiplex phenotypic cell-based high throughput screening assay to identify novel hepatitis C virus antivirals
2013 StandoutNobel
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
2016 StandoutNobel
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
2014 StandoutNobel
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of M.G.L. Pich being referenced
Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin
2007
Neurotransmitter Changes by Interferon-Alpha and Therapeutic Implications
2003
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C
2005